127 related articles for article (PubMed ID: 15870130)
1. Differential effects of gonadotropin-releasing hormone (GnRH)-I and GnRH-II on prostate cancer cell signaling and death.
Maiti K; Oh DY; Moon JS; Acharjee S; Li JH; Bai DG; Park HS; Lee K; Lee YC; Jung NC; Kim K; Vaudry H; Kwon HB; Seong JY
J Clin Endocrinol Metab; 2005 Jul; 90(7):4287-98. PubMed ID: 15870130
[TBL] [Abstract][Full Text] [Related]
2. Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells.
Montagnani Marelli M; Moretti RM; Mai S; Januszkiewicz-Caulier J; Motta M; Limonta P
J Clin Endocrinol Metab; 2009 May; 94(5):1761-7. PubMed ID: 19190109
[TBL] [Abstract][Full Text] [Related]
3. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
Gründker C; Emons G
Reprod Biol Endocrinol; 2003 Oct; 1():65. PubMed ID: 14594454
[TBL] [Abstract][Full Text] [Related]
4. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
[TBL] [Abstract][Full Text] [Related]
5. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
[TBL] [Abstract][Full Text] [Related]
8. GnRH-II analogs for selective activation and inhibition of non-mammalian and type-II mammalian GnRH receptors.
Maiti K; Li JH; Wang AF; Acharjee S; Kim WP; Im WB; Kwon HB; Seong JY
Mol Cells; 2003 Oct; 16(2):173-9. PubMed ID: 14651258
[TBL] [Abstract][Full Text] [Related]
9. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of GnRH receptor signaling: combinatorial cross-talk of Ca2+ and protein kinase C.
Naor Z; Harris D; Shacham S
Front Neuroendocrinol; 1998 Jan; 19(1):1-19. PubMed ID: 9465287
[TBL] [Abstract][Full Text] [Related]
11. A gonadotropin-releasing hormone-II antagonist induces autophagy of prostate cancer cells.
Kim DK; Yang JS; Maiti K; Hwang JI; Kim K; Seen D; Ahn Y; Lee C; Kang BC; Kwon HB; Cheon J; Seong JY
Cancer Res; 2009 Feb; 69(3):923-31. PubMed ID: 19176390
[TBL] [Abstract][Full Text] [Related]
12. Elevated GnRH receptor expression plus GnRH agonist treatment inhibits the growth of a subset of papillomavirus 18-immortalized human prostate cells.
Morgan K; Stavrou E; Leighton SP; Miller N; Sellar R; Millar RP
Prostate; 2011 Jun; 71(9):915-28. PubMed ID: 21541969
[TBL] [Abstract][Full Text] [Related]
13. Cetrorelix, a gonadotropin-releasing hormone antagonist, induces the expression of melatonin receptor 1a in the gonadotropin-releasing hormone neuronal cell line GT1-7.
Ishii H; Sato S; Yin C; Sakuma Y; Kato M
Neuroendocrinology; 2009; 90(3):251-9. PubMed ID: 19641296
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
Kraus S; Levy G; Hanoch T; Naor Z; Seger R
Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
[TBL] [Abstract][Full Text] [Related]
15. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
Gründker C; Völker P; Schulz KD; Emons G
Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
[TBL] [Abstract][Full Text] [Related]
16. Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor.
Naor Z
Front Neuroendocrinol; 2009 Jan; 30(1):10-29. PubMed ID: 18708085
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone in apoptosis of prostate cancer cells.
Kraus S; Naor Z; Seger R
Cancer Lett; 2006 Mar; 234(2):109-23. PubMed ID: 16546667
[TBL] [Abstract][Full Text] [Related]
18. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
[TBL] [Abstract][Full Text] [Related]
19. Signalling and anti-proliferative effects mediated by gonadotrophin-releasing hormone receptors after expression in prostate cancer cells using recombinant adenovirus.
Franklin J; Hislop J; Flynn A; McArdle CA
J Endocrinol; 2003 Feb; 176(2):275-84. PubMed ID: 12553876
[TBL] [Abstract][Full Text] [Related]
20. Evidence that signalling pathways by which thyrotropin-releasing hormone and gonadotropin-releasing hormone act are both common and distinct.
Kaiser UB; Katzenellenbogen RA; Conn PM; Chin WW
Mol Endocrinol; 1994 Aug; 8(8):1038-48. PubMed ID: 7527898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
